These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 26092263)

  • 21. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.
    Mahamud A; Masunu-Faleafaga Y; Walls L; Williams N; Garcia P; Teshale E; Williams R; Dulski T; Bellini WJ; Kutty PK
    Vaccine; 2013 Aug; 31(36):3683-7. PubMed ID: 23770334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.
    Ogbuanu IU; Kutty PK; Hudson JM; Blog D; Abedi GR; Goodell S; Lawler J; McLean HQ; Pollock L; Rausch-Phung E; Schulte C; Valure B; Armstrong GL; Gallagher K
    Pediatrics; 2012 Dec; 130(6):e1567-74. PubMed ID: 23129075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK; Chiu YL; Wilkin T
    AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909
    [No Abstract]   [Full Text] [Related]  

  • 26. Factors influencing MMR vaccination decisions following a mumps outbreak on a university campus.
    Hamilton-West K
    Vaccine; 2006 Jun; 24(24):5183-91. PubMed ID: 16650916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations.
    Hyle EP; Rao SR; Jentes ES; Parker Fiebelkorn A; Hagmann SHF; Taylor Walker A; Walensky RP; Ryan ET; LaRocque RC
    Ann Intern Med; 2017 Jul; 167(2):77-84. PubMed ID: 28505632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MMR Vaccine and Autism.
    DeStefano F; Shimabukuro TT
    Annu Rev Virol; 2019 Sep; 6(1):585-600. PubMed ID: 30986133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 30. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
    He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
    Paranthaman K; Bunce A
    Epidemiol Infect; 2012 Sep; 140(9):1612-6. PubMed ID: 22117122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mumps vaccine performance among university students during a mumps outbreak.
    Cortese MM; Jordan HT; Curns AT; Quinlan PA; Ens KA; Denning PM; Dayan GH
    Clin Infect Dis; 2008 Apr; 46(8):1172-80. PubMed ID: 18444852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
    Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notes from the Field: Complications of Mumps During a University Outbreak Among Students Who Had Received 2 Doses of Measles-Mumps-Rubella Vaccine - Iowa, July 2015-May 2016.
    Donahue M; Schneider A; Ukegbu U; Shah M; Riley J; Weigel A; James L; Wittich K; Quinlisk P; Cardemil C
    MMWR Morb Mortal Wkly Rep; 2017 Apr; 66(14):390-391. PubMed ID: 28406886
    [No Abstract]   [Full Text] [Related]  

  • 40. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.